MAIT cells monitor intestinal dysbiosis and contribute to host protection during colitis.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
21 Jun 2024
Historique:
medline: 21 6 2024
pubmed: 21 6 2024
entrez: 21 6 2024
Statut: ppublish

Résumé

Intestinal inflammation shifts microbiota composition and metabolism. How the host monitors and responds to such changes remains unclear. Here, we describe a protective mechanism by which mucosal-associated invariant T (MAIT) cells detect microbiota metabolites produced upon intestinal inflammation and promote tissue repair. At steady state, MAIT ligands derived from the riboflavin biosynthesis pathway were produced by aerotolerant bacteria residing in the colonic mucosa. Experimental colitis triggered luminal expansion of riboflavin-producing bacteria, leading to increased production of MAIT ligands. Modulation of intestinal oxygen levels suggested a role for oxygen in inducing MAIT ligand production. MAIT ligands produced in the colon rapidly crossed the intestinal barrier and activated MAIT cells, which expressed tissue-repair genes and produced barrier-promoting mediators during colitis. Mice lacking MAIT cells were more susceptible to colitis and colitis-driven colorectal cancer. Thus, MAIT cells are sensitive to a bacterial metabolic pathway indicative of intestinal inflammation.

Identifiants

pubmed: 38905325
doi: 10.1126/sciimmunol.adi8954
doi:

Substances chimiques

Riboflavin TLM2976OFR

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadi8954

Auteurs

Yara El Morr (Y)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Mariela Fürstenheim (M)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.
Université Paris Cité, Paris, France.

Martin Mestdagh (M)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Katarzyna Franciszkiewicz (K)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Marion Salou (M)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Claire Morvan (C)

Institut Pasteur, Université Paris Cité, UMR CNRS 6047, Laboratoire Pathogenèse des Bactéries Anaérobies, F-75015 Paris, France.

Thierry Dupré (T)

Laboratoire de Biochimie, Hôpital Bichat AP-HP, Université de Paris, Paris, France.

Alexey Vorobev (A)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Bakhos Jneid (B)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Virginie Premel (V)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Aurélie Darbois (A)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Laetitia Perrin (L)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Stanislas Mondot (S)

Institut Micalis, INRAE, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.

Ludovic Colombeau (L)

CNRS UMR 3666, INSERM U1143, Chemical Biology of Cancer Laboratory, PSL University, Institut Curie, 75005 Paris, France.

Hélène Bugaut (H)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Anastasia du Halgouet (A)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Sophie Richon (S)

Institut Curie, PSL Research University, CNRS UMR144, Paris, France.

Emanuele Procopio (E)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Mathieu Maurin (M)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.

Catherine Philippe (C)

Institut Micalis, INRAE, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.

Raphael Rodriguez (R)

CNRS UMR 3666, INSERM U1143, Chemical Biology of Cancer Laboratory, PSL University, Institut Curie, 75005 Paris, France.

Olivier Lantz (O)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.
Laboratoire d'immunologie clinique, Institut Curie, 75005 Paris, France.
Centre d'investigation Clinique en Biothérapie Gustave-Roussy Institut Curie (CIC-BT1428), Paris, France.

François Legoux (F)

Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.
INSERM ERL1305, CNRS UMR6290, Université de Rennes, Institut de Génétique & Développement de Rennes, Rennes, France.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH